Is the addition of adjuvant chemotherapy always necessary in node negative (N-) pre/perimenopausal breast cancer patients who receive goserelin? - Castiglione-Gertsch,M.; O'Neill,A.; Gelber,R.D.; Nasi,M.L.; Rabaglio,M.; Lindtner,J.; Crivellari,D.; Forbes,J.; Fey,M.; Perey,L.; Cortes-Funes,H.; Collins,J.; et al. (Proc Am Soc Clin Oncol, 2002)